Frédéric Legrand
Impact in
-
- Autoimmune and Inflammatory Disorders Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- CAR-T cell therapy research 1
-
- Genetic factors in colorectal cancer 2
- Lymphoma Diagnosis and Treatment 1
- Co-authors
- Rita Clementi (1 shared paper)Cesare Danesino (1 shared paper)Valentino Conter (1 shared paper)Carmela Fusco (1 shared paper)Maurizio Aricò (1 shared paper)Gritta Janka (1 shared paper)Clotilde Simon (4 shared papers)Sylvie Chevret (4 shared papers)
In The Last Decade
Frédéric Legrand
14 papers receiving 257 citations
Peers
Comparison fields: 5 of 44
- Hematology 65
- Pathology and Forensic Medicine 49
- Immunology 58
- Oncology 65
- Neurology 33
Countries citing papers authored by Frédéric Legrand
This map shows the geographic impact of Frédéric Legrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Legrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Legrand more than expected).
Fields of papers citing papers by Frédéric Legrand
This network shows the impact of papers produced by Frédéric Legrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Legrand. The network helps show where Frédéric Legrand may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Legrand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Familial hemophagocytic lymphohistiocytosis: how late can the onset be? | 2001 | 70 |
| 2 | 2023 | 63 | |
| 3 | 2020 | 32 | |
| 4 | 2020 | 25 | |
| 5 | 2021 | 21 | |
| 6 | 2021 | 13 | |
| 7 | 2020 | 12 | |
| 8 | 2014 | 9 | |
| 9 | 2020 | 7 | |
| 10 | 2010 | 5 | |
| 11 | 2023 | 2 | |
| 12 | 2024 | 2 | |
| 13 | 2016 | 1 | |
| 14 | 2018 | 1 |
About Frédéric Legrand
Frédéric Legrand is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery, having authored 14 papers that have together received 263 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Genetic factors in colorectal cancer (2 papers), Multiple and Secondary Primary Cancers (1 paper), Autoimmune and Inflammatory Disorders Research (1 paper), Cancer Genomics and Diagnostics (1 paper), CAR-T cell therapy research (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (65 citations), Pathology and Forensic Medicine (49 citations), Immunology (58 citations), Oncology (65 citations) and Neurology (33 citations). Frédéric Legrand has collaborated with scholars based in France, Italy and Spain. Frequent co-authors include Rita Clementi, Cesare Danesino, Valentino Conter, Carmela Fusco, Maurizio Aricò, Gritta Janka, Clotilde Simon, Sylvie Chevret, Assia Lamrani-Ghaouti and Esma Saâda-Bouzid. Their work appears in journals such as Annals of Oncology, Blood, Journal of Hypertension, Targeted Oncology and Circulation Cardiovascular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.